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The family of bone morphogenetic proteins. Bone morphoge- posed by Urist et al in their pioneering work demonstra-
netic proteins (BMPs) are secreted signaling molecules belong- ting that demineralized bone extracts could induce de
ing to the transforming growth factor-b (TGF-b) superfamily novo bone formation when implanted in ectopic sites in
of growth factors. The first BMPs were originally identified by
rats [1–3]. This process, which recapitulates all of thetheir ability to induce ectopic bone formation when implanted
events occurring during embryonic skeleton develop-under the skin of rodents. In this ectopic overexpression assay,
there was a recapitulation of all the events occurring during ment [4–6], from the beginning has generated a lot of
skeletogenesis. This latter aspect indicated that these molecules interest among bone biologists and developmental biolo-
could play important roles during development. More than 30 gists. Indeed, in a sequence that is now very well known,
BMPs have been identified to date. The study of their expres- the implant is first colonized by undifferentiated mesen-sion pattern as well as the analysis of spontaneously mutated or
chymal cells that differentiate into chondrocytes. Latergenetically depleted mice have demonstrated a much broader
on, vascular invasion occurs followed by osteoblast andrange of function. These activities are mainly localized at sites
of epithelial-mesenchymal interactions, including but not re- osteoclast differentiation preceding de novo bone forma-
stricted to the skeleton. This review presents our current knowl- tion. These experiments performed in the 1960s were
edge about the functions of BMPs during skeleton develop- followed by the cloning of the first BMPs more than 20
ment as well as in many other biologic processes.
years later, and the demonstration that these factors
could reproduce the bone-forming activity of the bone
extracts [7–12]. The molecular cloning of many BMP-Secreted molecules are key regulators of develop-
encoding genes and their identification as TGF-b rela-mental and regenerative processes, as they allow cells to
tives enhanced the interest in these molecules and al-communicate with each other and acquire their fate. In
lowed expression and functional studies to be performed.the last two decades, members of one subgroup of the
Unexpectedly, given the nature of the assay that led totransforming growth factor-b (TGF-b) superfamily of
the identification of these proteins, it became rapidlygrowth factors, termed generically as “bone morphoge-
evident that their pattern of expression, as well as theirnetic protein” (BMP), have been recognized as critical in
physiological functions, was not restricted to skeletoncontrolling multiple organogenetic processes. Comprising
development when it affects skeleton developmentan ever-growing number of identified homologues, the
[13–16]. These functions include cell proliferation andBMPs represents almost one third of the TGF-b super-
differentiation; apoptosis; morphogenesis; patterning offamily, with more than 30 members already described
various organs, including the skeleton; and organogene-(Fig. 1). Individually, the members of this subfamily of
sis [17–19]. Moreover, recent experiments have shownsecreted molecules are termed either BMPs, osteogenic
that several BMP family members cannot induce de novoproteins (OPs), cartilage-derived morphogenetic pro-
bone formation in the classic subcutaneous implantationteins (CDMPs), or growth and differentiation factors
assay [20], highlighting the functional heterogeneity of(GDFs). They have been classified into several sub-
this subfamily. Taking this important fact in account, our
groups according to their structural similarities (Fig. 1). review focuses not only on the few BMP family members
As extensive studies of their functions are being per- whose ability to ectopically form bone in this assay has
formed, it becomes increasingly evident that the name been demonstrated [10, 12, 21–25], but it also highlights
GDFs would be more accurate to describe this subfamily what has been learned, using mostly findings of mouse
than the historical term of BMPs. This name was pro- and human genetics, about the nonskeletal function of
particular BMPs in vivo.
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Fig. 1. Phylogenetic relationships between bone
morphogenic protein (BMP) family members.
Amino acid sequence identities were calculated
based on the ligand-binding domain sequence,
which is located downstream of the first conserved
cysteine residue. The length of the horizontal lines
connecting one sequence to another is propor-
tional to the estimated genetic distance between
the sequences. No asterisk, human/mouse pro-
tein; *Drosophila protein; **Xenopus protein;
***Sea urchin protein.
lytically cleaved at a consensus Arg-X-X-Arg site to yield all family members [30–32]. In general, BMPs have one
more conserved cysteine that is involved in intermolecu-carboxy-terminal mature dimers [7, 26, 27]. This cleavage
is thought to occur before secretion and subtilisin-like lar disulfide bonding, but some members of the family,
such as Gdf3 and Gdf9, lack this cysteine, suggesting thatconvertases (SCPs) have been implicated in this process
[28, 29]. It has been recently shown that the downstream covalent bonding is not required for dimerization [33].
Once secreted, the BMPs fulfill their signaling functionsequence adjacent to the cleavage site determines the
cleavage efficiency, while the N-terminal region controls by binding to an heterodimeric complex of two trans-
membrane receptors, termed type I and type II, withthe stability of the processed mature protein [29]. Analy-
sis of the crystal structure of two TGF-b family members, serine-threonine kinase activity [15, 26, 34]. The kinase
activity of the type II receptors is constitutive, whileTGF-b2 and BMP7, has revealed that the core of the
monomer is a cystine knot involving six cysteine residues ligand binding is required for type I receptor kinase
activation. Optimal ligand binding is achieved when boththat are invariably spaced in the C-terminal region of
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type I and type II receptors are present, although BMPs neural crest cells [43]. As development proceeds, Bmp4
transcripts become detectable in the mesoderm aroundcan bind to each of them weakly and subsequently recruit
the second subunit. Upon ligand binding, the type II the developing gut, in the myocardium, the branchial
arches, the developing eye, the otic vesicles, the neuro-receptor transphosphorylates the type I receptor at the
juxtaposition region activating the type I kinase [35, 36]. epithelium that is destined to associate with Rathke’s
pouch, and the dorsomedial telencephalon region thatThe latter then phosphorylates members of the Smad
family of transcription factors that are subsequently will give rise to the choroid plexus [43, 46, 48–50]. As it
is the case for Bmp2, Bmp4 transcripts can be foundtranslocated to the nucleus, where they activate the ex-
pression of target genes in concert with other transcrip- in both the epithelium and mesenchyme tissues of the
developing limb bud (mesoderm and apical ectodermaltion factors or coactivators [37–39]. It is not yet clear
whether Smads are able to recognize specific binding ridge) and tooth bud, suggesting that it also plays a role
in the epithelial–mesenchymal interactions that charac-sites and can bind alone to DNA.
terize skeleton and tooth development, as well as many
other organogenesis processes [46, 48].
PATTERN OF EXPRESSION OF BMPs
Bmp5 is expressed in the mesenchymal cells of the
If the expression pattern of a gene or a family of genes developing lung starting at 10.5 dpc. Thereafter, it is
is a reflection of its potential function, one would have expressed in the ureter and connective tissue-producing
predicted, given their restricted but spectacular function cells underlying the bladder in the presumptive gut, in
in vitro, that the genes encoding the various BMPs would the ventricular chamber of the heart, the meninges, and
be expressed preferentially if not exclusively in mesen- transiently in the telencephalon [43, 50, 51]. During skel-
chymal condensations prefiguring the future skeleton, etal development, Bmp5 expression marks some of the
in developing bones, and in differentiated chondrocytes mesenchymal condensations such as the genital tubercle,
and/or osteoblasts. As it turns out, this is not the case the sternum, the thyroid cartilage, the cartilage rings of
for any of the BMPs for which the pattern of expression the trachea, and the cells forming part of the vertebrae
has been described. The most extensive studies are sum- [45, 52, 53].
marized later in this article and illustrate the point that Bmp6 has also a broad pattern of expression. At 8.5
developing skeleton is neither the only nor the major dpc, it is expressed in the branchial pouch and in the
site of expression of the BMPs. endodermal component of the visceral yolk sac [50, 54].
Bmp2 expression can be detected as early as 8.5 days By 9.5 dpc, Bmp6 transcripts can be detected in the
postcoitum (dpc) in mesodermal cells of the amnion and roofplate of the neural tube [50]. In the developing heart,
chorion cells of the visceral endoderm, the allantois, and Bmp6 expression is restricted to the epithelium of the
the lateral plate mesoderm underlying the head fold [40– branchial pouch [40, 46]. Moreover, Bmp6 is expressed
42]. From 8.5 to 9.5, Bmp2 is also expressed in the dorsal in the developing kidney, where it marks the stromal
surface ectoderm underlying the neural tube [43]. cells surrounding the developing and mature tubercles,
Around 9.5 and 10.5 dpc, its expression can be detected and in the developing skin [39, 46]. In the developing
in the outer myocardial layer of the heart, in the apical skeleton, Bmp6 is expressed preferentially in hypertro-
ectodermal ridge, and in the zone of polarizing activity phic chondrocytes [45, 55].
of the developing limb [41–44]. Starting at 12.5 dpc, Bmp7 is another member of the family whose broad
Bmp2 expression is also observed in the mesenchymal expression has been extensively studied. It starts to be
condensation that will give rise to the ribs and vertebrae, expressed during early gastrulation, localizing in the ec-
in tooth buds, in the developing eye, and in whisker toderm of the periphery of the embryo [40, 42]. At 8.5
follicles [39, 43, 44]. Later during development, Bmp2 and 9.5 dpc, Bmp7 is strongly expressed in the surface
transcript can be observed in hypertrophic chondrocytes ectoderm and the notochord, in the neuroepithelium
of long bones and in forming digits [45]. extending toward the prospective forebrain, and in the
Bmp4, which encodes a close relative to Bmp2, starts developing gut [40, 43]. Bmp7 is also expressed in the
to be expressed as early as 6.5 dpc, around the time of atrial and ventricular chambers. This heart expression
gastrulation [46–48]. At 7.5 dpc, Bmp4 becomes widely will continue throughout development [43]. During eye
expressed in the embryo, marking the allantois, amnion, development, Bmp7 expression is detected in the surface
and the posterior part of the primitive streak [42, 46]. ectoderm, the lens placode, and the optic vesicle [40, 43,
At that stage, this expression is restricted to ectodermal 56, 57]. In the developing skeleton, Bmp7 is expressed in
tissues in the chicken embryo [42]. Between 8.5 and 9.5 the developing limb, in the mesenchymal cells localized
dpc, a strong Bmp4 expression can be observed in the between the developing digits, and in the chondrogenic
neural tube area, principally localized in the posterior zones [43, 50, 56, 57]. Bmp7 is also expressed in many
mesoderm and prospective diencephalon, but also pres- cells of the developing kidney, where it plays a critical
role (discussed later in this article). At 9.5 dpc, Bmp7ent in the dorsal surface ectoderm, and the presumptive
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transcripts are detected in the Wolffian ducts, which give phenotypes observed in the short ear mice to a single
function of the short ear gene during chondrocyte differ-rise to the ureteric buds. At 12.5 dpc, Bmp7 is expressed
predominantly in the ureteric bud epithelium, but a entiation [68, 70, 71]. This hypothesis was supported by
the finding, among others, that the abnormal shape orweaker expression is also detected in the surrounding
condensed mesenchymal cells. Later on, its transcripts absence of the xiphoid appendix was due to a delay in
the formation of the mesenchymal condensation prefig-are present in the same structures, but also in the pretu-
bular aggregates and the podocytes of the glomeruli. No uring it. The original hypothesis proved to be extremely
accurate, as it stated that the short ear gene causes “aexpression was detected in the comma- and S-shaped
bodies [56, 57]. slight reduction in the rate of formation of cartilage”
but not an arrest of differentiation, as chondrocytes andOther BMPs have not been shown to be expressed in
developing skeletal structures, but seem to be specifically osteoblasts are present, even in affected skeletal struc-
tures, in the short ear mice. This hypothesis could extendexpressed in particular tissues. For instance, Gdf9 is ex-
pressed in the ovaries, testis, and hypothalamus [58–60], to the nonskeletal phenotypes only if one assumes that
the “short ear gene” acts in multiple organs where it iswhereas Gdf8 expression is restricted to skeletal muscles
[61], and BMP10 expression appears to be restricted to expressed.
In a landmark study, 50 years after the hypothesis wasthe heart [62]. Finally, several other BMPs are expressed
more specifically in the developing nervous system, such proposed that the short ear gene was controlling cartilage
formation, Kingsley et al demonstrated that the geneas Gdf1, Gdf7, and Gdf11 [63–65].
From this long enumeration, a few common themes mutated or deleted in the short ear mice was the Bmp5
gene [72]. These authors went on to show that Bmp5 isemerge. The expression of the BMPs is often widespread
and dynamic as development proceeds. It is frequently expressed in the mesenchymal condensations outlining
the future skeleton elements that are affected as well aslocalized at areas of epithelial–mesenchymal interac-
in the periosteum [52]. Subsequently they showed thattions. It is found in many more tissues and organs than
Bmp5 is also expressed in lung, liver, bladder, and intes-the future skeleton, and sometime it interests the devel-
tines, all organs that are affected in the short ear miceoping skeleton only marginally. Thus, from these few
[52, 71]. A recent histomorphometric analysis revealedexamples, one could predict that the various BMPs could
that the absence of BMP5 led to a minimal increase inhave a broad range of physiologic functions during em-
growth plate height and growth rate, but no change in thebryonic development and beyond development.
number of proliferative and hypertrophic chondrocytes
[73].
SKELETAL ABNORMALITIES IN
BMP-DEFICIENT ANIMALS Brachypodism
Through identification of the mutated genes in classic Brachypodism (bp) is another classic mouse mutation
mouse mutants or through conventional gene-targeting that appears spontaneously on an outbred mouse strain
approaches, many BMP-encoding genes have been inac- in 1952 [74]. Affected animals are characterized by a
tivated. The chronology of publication of the molecular reduction in length of several long bones and the replace-
elucidation of these various mutations led initially to the ment of two bones in most digits by a single skeleton
belief that BMPs were acting mostly on skeletal develop- element [74, 75]. The product of the bp gene was thought
ment. However, a careful review of all of the mutants for a long time to act cell nonautonomously and to
available nowadays clearly indicates that this is an excep- control the formation of mesenchymal condensations
tion rather than a rule. We first review skeletal abnormal- [76, 77]. A similar approach was taken by the same group
ities in mice carrying a mutation in BMP-encoding genes that uncovered the involvement of Bmp5 in the short
and subsequently review the nonskeleton phenotypes. ear mutation to demonstrate that the brachyphodism
phenotype was due to frameshift mutations causing early
Recessive short ear mouse termination in the Gdf5 gene [78]. Gdf5 is a member of
The recessive short ear (se/se) mouse is a classic skele- the BMP subfamily that does not have bone-forming
ton-patterning mutant that has been very well studied activity but induces the formation of tendon and liga-
over the last 60 years [66–71]. The short ear mouse has ment structures in the classic subcutaneous implantation
many anatomical abnormalities: reduced size of the ear, assay used to identify the BMPs [20]. Consistent with
reduction in body size, reduction in the number of ribs, this pharmacological ability, Gdf5 is expressed during
misshapen or absence of the xiphoid appendix as well as joint formation in vivo [53, 79]. However, a mutation in
hydronephrosis, medial misplacement of the left gonad, the human GDF5 gene called CDMP1 has been impli-
giant cell granulomas of the liver, and lung abnormalities. cated in two recessive chondrodysplasia: the Hunter
Green, in a series of landmark studies, hypothesized Thompson chondrodysplasia and the chondrodysplasia
Grebe type [80–82]. Mutations in the CDMP1 gene alsothat it was possible to relate the variety of the skeletal
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cause autosomal dominant brachydactyly type C [83]. In the severity of the phenotype observed in other organs
(discussed later in this article). It indicates that the physi-in vitro studies, it was clear that overexpression of GDF5
increased the size of the mesenchymal condensations ologic functions of these proteins are different from their
pharmacological ability in two critical ways. Physiologi-without a major effect on chondrocyte proliferation [76,
77, 84]. This example illustrates the need to perform in cally, they control mesenchymal condensation but not
cell differentiation, at least in the skeleton, and theirvivo experiments to understand the physiological func-
tion of a particular molecule accurately. actions in soft tissues appear to be more important than
their actions in the skeleton.Another remarkable fact is that both Bmp5 and Gdf5
mutations in the same gene cause recessive phenotypes
in mouse and dominant ones in humans. This seems to
EXTRASKELETAL ABNORMALITIES IN
be a recurrent theme in the BMP field. Indeed, mice
BMP-DEFICIENT ANIMALS
heterozygous for a deletion of noggin, an inhibitor of
Consistent with their wide pattern of expression, muta-BMP action, have no overt phenotype whereas humans
tions in BMP-encoding genes can affect many organoge-heterozygous for a similar mutation develop a multiple
netic processes. Some of these mutations cause earlysynostosis phenotype [85, 86].
embryonic lethality, precluding for now the analysis ofMutations in Bmp5 and Gdf5 were the first mutations
the role of these proteins during skeleton development.to be identified in BMP-encoding genes, and they seemed
We review briefly some of these phenotypes, with a par-to indicate that the biologic function of all BMP proteins
ticular emphasis on BMP7, a gene product required forcould take place primarily if not only in the developing
glomeruli formation [56, 57]. Again, the purpose of thisskeleton. As reported later in this article, subsequent mu-
enumeration is to highlight the difference between thetagenesis experiments in other genes showed that it was
wealth of their biologic function and the remarkablenot to be the case. In fact, the mutations published in
pharmacology of this group of molecules.BMP-encoding genes other than Bmp5 or Gdf5 have at
Inactivating mutation in some Bmps can result in earlybest mild skeletal abnormalities. Homozygous Bmp2 or
embryonic lethality or in perinatal lethality, caused byBmp4 deletions in mice are embryonic lethal before the
profound extraskeletal defects. For instance, Bmp2-onset of skeletogenesis [41, 48]. Twelve percent of hetero-
deficient mice died between 7.0 and 10.5 dpc, the mutantzygote Bmp4-deficient mice have a preaxial polydactyly
phenotype being evident at 7.75 dpc [41]. The mutant[86]. Homozygous Bmp6-deficient mice have no skele-
embryo retained an open preamniotic canal and/or ex-ton-patterning defect and a mild delay of sternum ossifi-
hibited abnormal heart development. The maintenancecation that could be traced to the formation of the mesen-
of the preamniotic canal in an open state caused malfor-chymal condensations [45]. Homozygous Bmp7-deficient
mation of the amnion and the chorion. Heart develop-mice have patterning abnormalities of the ribs and a
ment occurred abnormally in the exocoelonic cavity.preaxial polydactyly in the hind limbs [56, 57]. As it is
Other abnormalities include delay in allantois develop-the case for the short ear mice, histologic examination
ment, open neural tubes, and overall slower growth offailed to detect any other abnormalities in chondrocyte
these embryos.and osteoblast differentiation in the Bmp7-deficient mice
Inactivating mutations in Bmp4 also causes embryonic[57].
lethality, this time between 6.5 and 9.5 dpc with a variableThe generation of mice harboring mutations in two
phenotype [48]. Most of the mutant embryos show virtu-different BMP-encoding genes adds little to this picture.
ally no mesodermal differentiation. Some embryos de-Bmp5/6 double mutant mice display only a slight exacer-
velop beyond 6.5 dpc and present disorganized posteriorbation of the sternal defect present in single mutants
structures, a reduction in extraembryonic mesoderm, and[45]. Mice carrying null mutations in both Gdf5 and
are overall developmentally retarded. More recently, itBmp5 have skeleton-patterning defects that are not seen
was shown that they contain no primordial germ andin any of the single mutants, but these abnormalities are
that lens induction does not occur in these embryosextremely localized and do not disturb the differentiation
[89, 90]. Bmp4 heterozygote-deficient mice present withof osteoblasts or chondrocytes [87]. Likewise, mice car-
a variable penetrance craniofacial malformation, mi-rying heterozygous mutations in both Bmp7 and Bmp4
crophthalmia, and preaxial polydactyly, indicating thathave a higher frequency of rib cage and digit abnormali-
Bmp4 gene dosage is essential for normal organogenesis.ties than single heterozygotes, suggesting that BMP7 and
The extent and the severity of the abnormalities re-BMP4 may act jointly in the formation of the affected
corded in the Bmp4 homozygous or heterozygous mu-mesenchymal condensations [88]. Finally, Bmp5/7 dou-
tant embryos mice emphasize the pleiotropic functionble mutant mice die early during embryogenesis, before
of the BMPs in vivo.the beginning of skeletogenesis [51].
Another BMP-encoding gene in which the deletionThe mild and/or extremely localized skeletal defects
observed in all these mutant mice contrast strongly with causes a perinatal lethality in mice is Bmp7 [56, 57].
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In the absence of Bmp7, there is a failure of kidney In summary, genetic and molecular studies have
morphogenesis, the deficient mice presenting small dys- helped define the paramount importance of the BMPs
genic kidneys that have less than 3 glomeruli per histo- in multiple physiologic processes. In fact, it is now clear
logic section compared with approximately 100 in normal that most of the BMPs studied so far have, in vivo,
mice. This defect was tracked down to a defect in epithe- profound and specific effects on organogenesis processes
lial–mesenchymal interaction occurring between 12.0 outside the skeleton. Because some of these effects lead
and 12.5 dpc and leading to cell death of the metanephric to embryonic lethality, it is possible that additional roles
mesenchymal cells. A series of molecular analyses sug- may have been underestimated. The possibility now ex-
gest that Bmp7 is one of the earliest glomeruli inducers. ists to perform cell-specific and time-specific experiments
Bmp7 deficiency also causes, with incomplete pene- on genes at will. Most likely, when they are performed
trance, an absence of lens induction and eye formation. these studies will determine the extent of the physiologic
This latter phenotype is reminiscent to what is observed role of the BMPs during development.
in Bmp4-deficient embryos. This is important as it sug-
Reprint requests to Gerard Karsenty, M.D., Department of Moleculargests that, at least during lens formation, redundancy
and Human Genetics, Baylor College of Medicine, One Baylor Plaza
between BMPs may not prevent abnormalities to occur. Room S930, Houston, Texas 77003, USA.
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have also many nonskeletal phenotypes, although none
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